Marion McCourt
CIK: 0001663758
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
REGENERON PHARMACEUTICALS, INC.
Discretionary Trading P&L
Holdings
Transaction History (15 total)
- Oct 30, 2026REGN
REGENERON PHARMACEUTICALS, INC.
Sale(S)Direct1.1K shares at avg. $869.43$984K - Sep 3, 2026REGN
REGENERON PHARMACEUTICALS, INC.
Sale(S)Direct1.1K shares at avg. $857.39$970K - Sep 2, 2026REGN
REGENERON PHARMACEUTICALS, INC.
Sale(S)Direct1.2K shares at avg. $850.00$1.0M - Dec 9, 2025REGN
REGENERON PHARMACEUTICALS, INC.
Tax Payment(F)Direct1K shares at avg. $701.51$716K - Dec 8, 2025REGN
REGENERON PHARMACEUTICALS, INC.
Tax Payment(F)Direct1.3K shares at avg. $712.94$952K - Dec 5, 2025REGN
REGENERON PHARMACEUTICALS, INC.
Award(A)Direct2.5K shares- - Dec 16, 2024REGN
REGENERON PHARMACEUTICALS, INC.
Tax Payment(F)Direct759 shares at avg. $730.81$555K - Dec 9, 2024REGN
REGENERON PHARMACEUTICALS, INC.
Tax Payment(F)Direct274 shares at avg. $787.00$216K - Dec 6, 2024REGN
REGENERON PHARMACEUTICALS, INC.
Award(A)Direct2.3K shares- - Nov 1, 2024REGN
REGENERON PHARMACEUTICALS, INC.
Exercise(M)Direct1K shares at avg. $381.40$381K - Nov 1, 2024REGN
REGENERON PHARMACEUTICALS, INC.
Sale(S)Direct1K shares at avg. $844.61$845K - Oct 1, 2024REGN
REGENERON PHARMACEUTICALS, INC.
Exercise(M)Direct1K shares at avg. $381.40$381K - Oct 1, 2024REGN
REGENERON PHARMACEUTICALS, INC.
Sale(S)Direct1K shares at avg. $1054.06$1.1M - Sep 3, 2024REGN
REGENERON PHARMACEUTICALS, INC.
Sale(S)Direct1K shares at avg. $1178.73$1.2M - Sep 3, 2024REGN
REGENERON PHARMACEUTICALS, INC.
Exercise(M)Direct1K shares at avg. $381.40$381K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 30, 2026 | REGN REGENERON PHARMACEUTICALS, INC. | Sale(S) | 1,132 | $869.43 | $984,195 | Direct |
| Sep 3, 2026 | REGN REGENERON PHARMACEUTICALS, INC. | Sale(S) | 1,131 | $857.39 | $969,708 | Direct |
| Sep 2, 2026 | REGN REGENERON PHARMACEUTICALS, INC. | Sale(S) | 1,215 | $850.00 | $1,032,750 | Direct |
| Dec 9, 2025 | REGN REGENERON PHARMACEUTICALS, INC. | Tax Payment(F) | 1,021 | $701.51 | $716,242 | Direct |
| Dec 8, 2025 | REGN REGENERON PHARMACEUTICALS, INC. | Tax Payment(F) | 1,336 | $712.94 | $952,488 | Direct |
| Dec 5, 2025 | REGN REGENERON PHARMACEUTICALS, INC. | Award(A) | 2,476 | - | - | Direct |
| Dec 16, 2024 | REGN REGENERON PHARMACEUTICALS, INC. | Tax Payment(F) | 759 | $730.81 | $554,685 | Direct |
| Dec 9, 2024 | REGN REGENERON PHARMACEUTICALS, INC. | Tax Payment(F) | 274 | $787.00 | $215,638 | Direct |
| Dec 6, 2024 | REGN REGENERON PHARMACEUTICALS, INC. | Award(A) | 2,332 | - | $0 | Direct |
| Nov 1, 2024 | REGN REGENERON PHARMACEUTICALS, INC. | Exercise(M) | 1,000 | $381.40 | $381,400 | Direct |
| Nov 1, 2024 | REGN REGENERON PHARMACEUTICALS, INC. | Sale(S) | 1,000 | $844.61 | $844,610 | Direct |
| Oct 1, 2024 | REGN REGENERON PHARMACEUTICALS, INC. | Exercise(M) | 1,000 | $381.40 | $381,400 | Direct |
| Oct 1, 2024 | REGN REGENERON PHARMACEUTICALS, INC. | Sale(S) | 1,000 | $1054.06 | $1,054,060 | Direct |
| Sep 3, 2024 | REGN REGENERON PHARMACEUTICALS, INC. | Sale(S) | 1,000 | $1178.73 | $1,178,730 | Direct |
| Sep 3, 2024 | REGN REGENERON PHARMACEUTICALS, INC. | Exercise(M) | 1,000 | $381.40 | $381,400 | Direct |
1-15 of 15 transactions
About McCourt Marion
McCourt Marion (SEC CIK 0001663758) files insider reports with the SEC as EVP Commercial of REGENERON PHARMACEUTICALS, INC. (REGN).
Signal8 holds 9 ownership filings by McCourt Marion, all Form 4s, filed between Sep 5, 2024 and Nov 3, 2026. Those filings report 15 transactions, from Sep 3, 2024 to Oct 30, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on McCourt Marion's filings is in TARRYTOWN, NY.
Recent filings by McCourt Marion
- Oct 30, 2026: Open-market sale of REGN shares (Form 4, code S).
- Sep 3, 2026: Open-market sale of REGN shares (Form 4, code S).
- Sep 2, 2026: Open-market sale of REGN shares (Form 4, code S).
- Dec 9, 2025: Tax withholding of REGN shares (Form 4, code F).
- Dec 8, 2025: Tax withholding of REGN shares (Form 4, code F).
Other insiders filing for REGENERON PHARMACEUTICALS, INC. (REGN)
- Guarini Kathryn, Director
- BROWN MICHAEL S, Director
- MURPHY ANDREW J, Co-Chief Scientific Officer
- LAROSA JOSEPH J, EVP General Counsel and Secret
- Fenimore Christopher R., EVP Finance CFO
- Zoghbi Huda Y, Director